Cytek Biosciences (CTKB) Interest Expenses (2020 - 2026)

Cytek Biosciences' Interest Expenses history runs 7 years deep, the most recent figure standing at $20.5 million for Q1 2026.

• Quarterly Interest Expenses fell 52.69% year-over-year to $20.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.5 million (down 52.69% YoY) and the FY2025 annual result came in at $21.3 million, up 97.22% from the prior year.
• Interest Expenses was $20.5 million for Q1 2026 at Cytek Biosciences, up from -$101000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $47.7 billion in Q1 2022 and bottomed at -$5.9 million in Q4 2024.
• A 5-year average of $5.5 billion and a median of $12.8 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses surged 12713088.53% — and 2024, when it slumped 1605.84%.
• Cytek Biosciences' Interest Expenses stood at $687000.0 in 2022, then slumped by 42.65% to $394000.0 in 2023, then slumped by 1605.84% to -$5.9 million in 2024, then jumped by 98.3% to -$101000.0 in 2025, then surged by 20400.0% to $20.5 million in 2026.
• Business Quant data shows CTKB's Interest Expenses at $20.5 million in Q1 2026, -$101000.0 in Q4 2025, and $21.0 million in Q3 2025.